0001209191-21-011596.txt : 20210217
0001209191-21-011596.hdr.sgml : 20210217
20210217204000
ACCESSION NUMBER: 0001209191-21-011596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210215
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kroll Werner
CENTRAL INDEX KEY: 0001609320
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 21647282
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-15
0
0000353569
QUIDEL CORP /DE/
QDEL
0001609320
Kroll Werner
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
SVP, R&D
Common Stock
2021-02-15
4
A
0
7172
0.00
A
15464
D
Common Stock
2021-02-15
4
F
0
3683
227.97
D
11781
D
Restricted Stock Units
2021-02-15
4
M
0
7172
0.00
D
Common Stock
7172
0
D
Reflects release of restricted stock units that were previously reported on a Form 4.
The amount of securities beneficially owned following this transaction include an additional 67 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Restricted stock units convert into common stock on a one-for-one basis.
7,172 shares vested on the fourth anniversary date of the grant date, February 15, 2021.
Robert J. Bujarski, attorney-in-fact for Werner Kroll
2021-02-17